GENE is the ticker symbol for Genetic Technologies Ltd, a biotechnology company that develops genetic risk assessment tests for various diseases1. According to Nasdaq, GENE was up 14.29% in pre-market trading as of Nov 01, 20212. One possible reason for this surge is the company’s announcement on Oct 29, 2021, that it had received a patent from the US Patent and Trademark Office for its breast cancer risk test3. This test, called GeneType for Breast Cancer, uses a combination of genetic and clinical factors to estimate a woman’s lifetime risk of developing breast cancer3. The patent is expected to strengthen the company’s intellectual property portfolio and enhance its market position in the US3.
1: Genetic Technologies Ltd ADS (GENE) Pre-Market Quotes | Nasdaq 2: (GENE) Latest Pre Market Trades | Nasdaq 3: Genetic Technologies Ltd. Announces Issuance of U.S. Patent for Breast Cancer Risk Test
GENE is the ticker symbol for Genetic Technologies Ltd, a...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.08M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| GTG (ASX) Chart |
Day chart unavailable